Publication | Open Access

In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach

Drug TargetCell Surface BipMedicineImmunologyAntiviral Drug DevelopmentSilico IdentificationAvailable DrugsAntiviral DrugViral Structural ProteinPharmacologyDrug Discovery